Browse > Article
http://dx.doi.org/10.4014/jmb.1504.04062

Large-Scale Refolding and Enzyme Reaction of Human Preproinsulin for Production of Human Insulin  

Kim, Chang-Kyu (Division of Animal Resources and Life Science, Sangji University)
Lee, Seung-Bae (Division of Animal Resources and Life Science, Sangji University)
Son, Young-Jin (Department of Pharmacy, Sunchon National University)
Publication Information
Journal of Microbiology and Biotechnology / v.25, no.10, 2015 , pp. 1742-1750 More about this Journal
Abstract
Human insulin is composed of 21 amino acids of an A-chain and 30 amino acids of a B-chain. This is the protein hormone that has the role of blood sugar control. When the recombinant human proinsulin is expressed in Escherichia coli, a serious problem is the formation of an inclusion body. Therefore, the inclusion body must be denatured and refolded under chaotropic agents and suitable reductants. In this study, H27R-proinsulin was refolded from the denatured form with β-mercaptoethanol and urea. The refolding reaction was completed after 15 h at $15^{\circ}C$, whereas the reaction at $25^{\circ}C$ was faster than that at $15^{\circ}C$. The refolding yield at $15^{\circ}C$ was 17% higher than that at $25^{\circ}C$. The refolding reaction could be carried out at a high protein concentration (2 g/l) using direct refolding without sulfonation. The most economical and optimal refolding condition for human preproinsulin was 1.5 g/l protein, 10 mM glycine buffer containing 0.6 M urea, pH 10.6, and 0.3 mM β-mercaptoethanol at $15^{\circ}C$ for 16 h. The maximum refolding yield was 74.8% at $15^{\circ}C$ with 1.5 g/l protein. Moreover, the refolded preproinsulin could be converted into normal mature insulin with two enzymes. The average amount of human insulin was 138.2 g from 200 L of fermentation broth after enzyme reaction with H27R-proinsulin. The direct refolding process for H27R-proinsulin was successfully set up without sulfonation. The step yields for refolding and enzyme reaction were comparatively high. Therefore, our refolding process for production of recombinant insulin may be beneficial to the large-scale production of other biologically active proteins.
Keywords
Preproinsulin; refolding; enzyme reaction; pilot scale;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Clark EDB. 1998. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9: 157-163.   DOI
2 Cousens LS, Shuster JR, Gallegos C, Ku L, Stempien MM, Urdea MS, et al. 1987. High level expression of proinsulin in the yeast Saccharomyces cerevisiae. Gene 61: 265-275.   DOI
3 Cowley DJ, Mackin RB. 1997. Expression, purification and characterization of recombinant human proinsulin. FEBS Lett. 402: 124-130.   DOI
4 Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.   DOI
5 Fischer BH, Sumner I, Goodenough P. 1993. Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnol. Bioeng. 41: 3-13.   DOI
6 Gu Z, Weidenhaupt M, Ivanova N, Pavlov M, Xu B, Su ZG, Janson JC. 2002. Chromatographic methods for the isolation of, and refolding of proteins from Escherichia coli inclusion bodies. Protein Exp. Purif. 25: 174-179.   DOI
7 Kim CK, Lee SM, Jeong SM. 2010. High cell density cultivation of recombinant Escherichia coli for production of rat procarboxypeptidase B. Food Sci. Biotechnol. 19: 1627-1633.   DOI
8 Lee SY, Oh SJ, Kim CK, Son YJ, Park KH, Min CK, et al. 2006. Plasmids expressing human insulin and the preparation method for human insulin thereby. United States Patent Application Publication US 2006, 0035316 A1.
9 Lilie H, Schwarz E, Rudolph R. 1998. Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol. 9: 497-501.   DOI
10 Linde S, Welinder BS, Nielsen JH. 1993. Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid-chromatography. J. Chromatogr. B 614: 185-204.   DOI
11 Markussen J. 1985. Comparative reduction/oxidation studies with single chain des-(B30) insulin and porcine proinsulin. Int. J. Pept. Protein Res. 25: 431-434.   DOI
12 Qiao ZS, Guo ZY, Feng YM. 2001. Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro. Biochemistry 40: 2662-2668.   DOI
13 Murray HD, Appleman JA, Gourse RL. 2003. Regulation of the Escherichia coli rrnB P2 promoter. J. Bacteriol. 185: 28-34.   DOI
14 Naglak TJ, Wang HY. 1990. Recovery of a foreign protein from the periplasm of Escherichia coli by chemical permeabilization. Enzyme Microb. Technol. 12: 603-611.   DOI
15 Nilsson J, Jonasson P, Samuelsson E, Stahl S, Uhlen M. 1996. Integrated production of human insulin and its C-peptide. J. Biotechnol. 48: 241-250.   DOI
16 Rudolph R, Lilie H. 1996. In vitro folding of inclusion body proteins. FASEB J. 10: 49-56.   DOI
17 Schnaitman CA. 1971. Effect of ethylene diamine tetraacetic acid, Triton X-100, and lysozyme on the morphology and chemical composition of isolated cell walls of Escherichia coli. J. Bacteriol. 108: 553-563.
18 Middelberg APJ, O’Neill BK. 1991. Monitoring the centrifugal recovery of recombinant protein inclusion bodies. Aust. J. Biotechnol. 5: 87-92.
19 Middelberg APJ. 2002. Preparative protein refolding. Trends Biotechnol. 20: 437-443.   DOI
20 Schutte H, Kula MR. 1990. Pilot- and process-scale techniques for cell disruption. Biotechnol. Appl. Biochem. 12: 599-620.
21 Son YJ, Kim CK, Choi BT, Park YC, Seo JH. 2008. Effects of β-mercaptoethanol and hydrogen peroxide on enzymatic conversion of human proinsulin to insulin. J. Microbiol. Biotechnol. 18: 983-989.
22 Enfors SO. 1992. Control of in vivo proteolysis in the production of recombinant proteins. TIBTECH 10: 310-315.   DOI
23 Son YJ, Park KH, Lee SY, Oh SJ, Kim CK, Choi BT, et al. 2007. Effect of temperature shift strategies on human preproinsulin production in the fed-batch fermentation of recombinant E. coli. Biotechnol. Bioprocess Eng. 12: 556-561.   DOI
24 Tikhonov RV, Pechenov SE, Belacheu IA, Yakimov SA, Klyushnichenko VE, Boldireva EF, et al. 2001. Recombinant human insulin VIII. Isolation of fusion protein-S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells. Protein Exp. Purif. 21: 176-182.   DOI
25 Tsumoto K, Ejima D, Kumagai I, Arakawa T. 2003. Practical considerations in refolding proteins from inclusion bodies. Protein Exp. Purif. 28: 1-8.   DOI
26 Walsh G. 2005. Therapeutic insulins and their large-scale manufacture. Appl. Microbiol. Biotechnol. 67: 151-159.   DOI
27 Wang XM, Guo ZY. 2013. Recombinant expression, different downstream processing of the disulfide-rich anti-tumor peptide Ranpirnase and its effect on the growth of human glioma cell line SHG-44. Biomed. Rep. 5: 747-750.
28 Yon JM, Betton JM. 1991. Protein folding in vitro and in the cellular environment. Biol. Cell 71: 17-23.   DOI
29 Mukhopadhyay A. 1997. Inclusion bodies and purification of proteins in biologically active forms. Adv. Biochem. Eng. Biotechnol. 56: 61-109.
30 Son YJ, Kim CK, Kim YB, Kweon DH, Park YC, Seo JH. 2009. Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B. Biotechnol. Prog. 25: 1064-1070.   DOI
31 Clark EDB. 2001. Protein refolding for industrial processes. Curr. Opin. Biotechnol. 12: 202-207.   DOI
32 Bailey SM, Meagher MM. 2000. Separation of soluble protein from inclusion bodies in Escherichia coli lysate using crossflow microfiltration. J. Membr. Sci. 166: 137-146.   DOI
33 Bowden GA, Paredles AM, Georgiou G. 1991. Expression vectors based on the rac fusion promoter. Gene 42: 97-100.
34 Castellanos Serra LR, Hardy E, Ubieta R, Vispo NS, Fernandez C, Besada V, et al. 1996. Expression and folding of an interleukin-2-proinsulin fusion protein and its conversion into insulin by a single step enzymatic removal of the Cpeptide and the N-terminal fused sequence. FEBS Lett. 378: 171-176.   DOI